Clinical characteristics of the BREATHE cohort – a real-life study on patients with asthma and COPD

References

• Costa DJ, Amouyal M, Lambert P, et al. How representative are clinical study patients with allergic rhinitis in primary care? J Allergy Clin Immunol. 2011;127:920–6.e1.
   PubMed Web of Science ®Google Scholar
• Herland K, Akselsen J-P, Skjonsberg OH, et al. How representative are clinical study patients with asthma or COPD for a larger “real life” population of patients with obstructive lung disease? Respir Med. 2005;99:11–11.
   PubMed Web of Science ®Google Scholar
• Price D, Brusselle G, Roche N, et al. Real-world research and its importance in respiratory medicine. Breathe (Sheffield, England). 2015;11:26–38.
   PubMedGoogle Scholar
• Roche N, Reddel H, Martin R, et al. Quality standards for real-world research. Focus on observational database studies of comparative effectiveness. Ann Am Thorac Soc. 2014;11(Suppl 2):S99–104.
   PubMedGoogle Scholar
• Saturni S, Bellini F, Braido F, et al. Randomized controlled trials and real life studies. Approaches and methodologies: a clinical point of view. Pulm Pharmacol Ther. 2014;27:129–138.
   PubMed Web of Science ®Google Scholar
• Price D, Hillyer EV, van der Molen T. Efficacy versus effectiveness trials: informing guidelines for asthma management. Curr Opin Allergy Clin Immunol. 2013;13:50–57.
   Web of Science ®Google Scholar
• Teague WG, Phillips BR, Fahy JV, et al. Baseline features of the Severe Asthma Research Program (SARP III) cohort: differences with age. J Allergy Clin Immunol Pract. 2018;6:545–554.e4.
   PubMed Web of Science ®Google Scholar
• Shaw DE, Sousa AR, Fowler SJ, et al. Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort. Eur Respir J. 2015;46:1308–1321.
   PubMed Web of Science ®Google Scholar
• von Bulow A, Kriegbaum M, Backer V, et al. The prevalence of severe asthma and low asthma control among Danish adults. J Allergy Clin Immunol Pract. 2014;2:759–767.
   PubMed Web of Science ®Google Scholar
• Barnes PJ, Woolcock AJ. Difficult asthma. Eur Respir J. 1998;12:1209–1218.
   PubMed Web of Science ®Google Scholar
• Darveaux J, Busse WW. Biologics in asthma–the next step toward personalized treatment. J Allergy Clin Immunol Pract. 2015;3:152–160. quiz 161.
   Google Scholar
• Barnes PJ. New anti-inflammatory targets for chronic obstructive pulmonary disease. Nat Rev Drug Discov. 2013;12:543–559.
   PubMed Web of Science ®Google Scholar
• Juniper EF, Svensson K, Mork A-C, et al. Measurement properties and interpretation of three shortened versions of the asthma control questionnaire. Respir Med. 2005;99:553–558.
   PubMed Web of Science ®Google Scholar
• Nathan RA, Sorkness CA, Kosinski M, et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol. 2004;113:59–65.
   PubMed Web of Science ®Google Scholar
• Jones PW, Harding G, Berry P, et al. Development and first validation of the COPD assessment test. Eur Respir J. 2009;34:648–654.
   PubMed Web of Science ®Google Scholar
• Council MR. Medical research council dyspnoea scale. 2016-12-01. Available from: https://mrc.ukri.org/research/facilities-and-resources-for-researchers/mrc-scales/mrc-dyspnoea-scale-mrc-breathlessness-scale/.
   Google Scholar
• Jenkinson C, Layte R. Development and testing of the UK SF-12 (short form health survey). J Health Serv Res Policy. 1997;2:14–18.
   PubMedGoogle Scholar
• Juniper EF, Guyatt GH, Cox FM, et al. Development and validation of the mini asthma quality of life questionnaire. Eur Respir J. 1999;14:32–38.
   PubMed Web of Science ®Google Scholar
• Juniper EF, Thompson AK, Ferrie PJ, et al. Development and validation of the mini rhinoconjunctivitis quality of life questionnaire. Clin Exp Allergy. 2000;30:132–140.
   PubMed Web of Science ®Google Scholar
• Damato S, Bonatti C, Frigo V, et al. Validation of the clinical COPD questionnaire in Italian language. Health Qual Life Outcomes. 2005;3:9.
   PubMedGoogle Scholar
• Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–370.
   PubMed Web of Science ®Google Scholar
• van Dixhoorn J, Folgering H. The Nijmegen Questionnaire and dysfunctional breathing. ERJ Open Res. 2015;1:00001–2015.
   Google Scholar
• Hopkins C, Gillett S, Slack R, et al. Psychometric validity of the 22-item sinonasal outcome test. Clin Otolaryngol. 2009;34:447–454.
   PubMed Web of Science ®Google Scholar
• Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14:540–545.
   PubMed Web of Science ®Google Scholar
• Caminha GP, Pizzichini E, Lubianca Neto JF, et al. Rhinosinusitis symptoms, smoking and COPD: prevalence and associations. Clin Otolaryngol. 2018;43:1560–1565.
   PubMed Web of Science ®Google Scholar
• American Thoracic Society; European Respiratory Society recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide. Am J Respir Crit Care Med. 2005;2005(171):912–930.
   Google Scholar
• Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319–338.
   PubMed Web of Science ®Google Scholar
• Johnson DC. Importance of adjusting carbon monoxide diffusing capacity (DLCO) and carbon monoxide transfer coefficient (KCO) for alveolar volume. Respir Med. 2000;94:28–37.
   Web of Science ®Google Scholar
• Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows. Report working party standardization of lung function tests, European community for steel and coal. official statement of the European respiratory society. Eur Respir J Suppl 1993;16:5–40.
   PubMedGoogle Scholar
• GINA. Global initiative for asthma: asthma management and prevention. Pract Nurse. 2019;2019:1–201.
   Google Scholar
• Anderson SD, Brannan J, Spring J, et al. A new method for bronchial-provocation testing in asthmatic subjects using a dry powder of mannitol. Am J Respir Crit Care Med. 1997;156:758–765.
   PubMed Web of Science ®Google Scholar
• Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43:343–373.
   PubMed Web of Science ®Google Scholar
• Singh D, Agusti A, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019. Eur Respir J. 2019;53:1900164.
   Web of Science ®Google Scholar
• Pavord ID, Korn S, Howarth P, et al. Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial. Lancet. 2012;380:651–659.
   PubMed Web of Science ®Google Scholar
• Bafadhel M, McCormick M, Saha S, et al. Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease. Respiration. 2012;83:36–44.
   PubMed Web of Science ®Google Scholar
• Simpson JL, McElduff P, Gibson PG. Assessment and reproducibility of non-eosinophilic asthma using induced sputum. Respiration. 2010;79:147–151.
   PubMed Web of Science ®Google Scholar
• Simpson JL, Scott R, Boyle MJ, et al. Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology. 2006;11:54–61.
   PubMed Web of Science ®Google Scholar
• Wijnant SRA, Lahousse L, De Buyzere ML, et al. Prevalence of asthma and COPD and blood eosinophil count in a middle-aged belgian population. J Clin Med. 2019;8:1122.
   Web of Science ®Google Scholar
• Moore WC, Bleecker ER, Curran-Everett D, et al. Characterization of the severe asthma phenotype by the national heart, lung, and blood institute’s severe asthma research program. J Allergy Clin Immunol. 2007;119:405–413.
   PubMed Web of Science ®Google Scholar
• Radhakrishna N, Tay TR, Hore-Lacy F, et al. Profile of difficult to treat asthma patients referred for systematic assessment. Respir Med. 2016;117:166–173.
   PubMed Web of Science ®Google Scholar
• Porsbjerg C, Menzies-Gow A. Co-morbidities in severe asthma: clinical impact and management. Respirology. 2017;22:651–661.
   PubMed Web of Science ®Google Scholar
• Ballarin A, Bazzan E, Zenteno RH, et al. Mast cell infiltration discriminates between histopathological phenotypes of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;186:233–239.
   PubMed Web of Science ®Google Scholar
• Sverrild A, Bergqvist A, Baines KJ, et al. Airway responsiveness to mannitol in asthma is associated with chymase-positive mast cells and eosinophilic airway inflammation. Clin Exp Allergy. 2016;46:288–297.
   PubMed Web of Science ®Google Scholar
• Stolz D, Anderson SD, Gysin C, et al. Airway reactivity to inhaled mannitol in cigarette smokers: a longitudinal study. Respir Med. 2007;101:1470–1476.
   PubMed Web of Science ®Google Scholar
• Aaron SD, Vandemheen KL, FitzGerald JM, et al. Reevaluation of diagnosis in adults with physician-diagnosed asthma. JAMA. 2017;317:269–279.
   PubMed Web of Science ®Google Scholar
• Haldar P, Pavord ID, Shaw DE, et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med. 2008;178:218–224.
   PubMed Web of Science ®Google Scholar
• von Bulow A, Backer V, Bodtger U, et al. Differentiation of adult severe asthma from difficult-to-treat asthma - outcomes of a systematic assessment protocol. Respir Med. 2018;145:41–47.
   Web of Science ®Google Scholar
• Backer V, Sverrild A, Ulrik CS, et al. Diagnostic work-up in patients with possible asthma referred to a university hospital. Eur Clin Respir J. 2015;2:27768.
   Web of Science ®Google Scholar